Clinical practice. Calcium kidney stones
- PMID: 20818905
- PMCID: PMC3192488
- DOI: 10.1056/NEJMcp1001011
Clinical practice. Calcium kidney stones
Comment in
-
Calcium kidney stones.N Engl J Med. 2010 Dec 16;363(25):2470; author reply 2471. doi: 10.1056/NEJMc1011349. N Engl J Med. 2010. PMID: 21158673 No abstract available.
-
Calcium kidney stones.N Engl J Med. 2010 Dec 16;363(25):2470; author reply 2471. doi: 10.1056/NEJMc1011349. N Engl J Med. 2010. PMID: 21158674 No abstract available.
Similar articles
-
Use of the discriminant index in dynamic treatment to reduce recurrence of calcium oxalate kidney stones.Br J Urol. 1985 Oct;57(5):500-4. doi: 10.1111/j.1464-410x.1985.tb05855.x. Br J Urol. 1985. PMID: 2998532
-
Medical management of nephrolithiasis.J Urol. 1982 Dec;128(6):1157-64. doi: 10.1016/s0022-5347(17)53403-5. J Urol. 1982. PMID: 6759686 Clinical Trial. No abstract available.
-
Consensus development summaries. Prevention and treatment of kidney stones. National Institutes of Health.Conn Med. 1988 Jul;52(7):415-20. Conn Med. 1988. PMID: 3215027 No abstract available.
-
Prevention and treatment of kidney stones.J Urol. 1989 Mar;141(3 Pt 2):804-8. doi: 10.1016/s0022-5347(17)41015-9. J Urol. 1989. PMID: 2645439 Review. No abstract available.
-
Consensus conference. Prevention and treatment of kidney stones.JAMA. 1988 Aug 19;260(7):977-81. JAMA. 1988. PMID: 3294456 Review. No abstract available.
Cited by
-
Discovery of l-Lysine Dioxalate (LH1513) as a Novel Inhibitor of Calcium Oxalate Crystallization for Hyperoxaluria.ACS Med Chem Lett. 2024 Nov 4;15(11):2005-2011. doi: 10.1021/acsmedchemlett.4c00423. eCollection 2024 Nov 14. ACS Med Chem Lett. 2024. PMID: 39563801
-
Correlation analysis between urinary crystals and upper urinary calculi.Asian J Urol. 2024 Oct;11(4):596-603. doi: 10.1016/j.ajur.2024.04.003. Epub 2024 May 3. Asian J Urol. 2024. PMID: 39534003 Free PMC article.
-
Optimization of Plant Oxalate Quantification and Generation of Low-Oxalate Maize (Zea mays L.) through O7 Overexpression.Plants (Basel). 2024 Oct 22;13(21):2950. doi: 10.3390/plants13212950. Plants (Basel). 2024. PMID: 39519867 Free PMC article.
-
Between a Rock and a Short Place-The Impact of Nephrolithiasis on Skeletal Growth and Development Across the Lifespan.Curr Osteoporos Rep. 2024 Dec;22(6):576-589. doi: 10.1007/s11914-024-00888-w. Epub 2024 Oct 2. Curr Osteoporos Rep. 2024. PMID: 39356465 Review.
-
Risk Factors of Asymptomatic Kidney Stone Passage in Adults with Recurrent Kidney Stones.Clin J Am Soc Nephrol. 2024 Jul 19;19(9):1130-7. doi: 10.2215/CJN.0000000000000496. Online ahead of print. Clin J Am Soc Nephrol. 2024. PMID: 39028573
References
-
- Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Jr, Curhan GC. Time trends in reported pevalence of kidney stones in the United States:1976–1994. Kid Int. 2003;63:1817–1823. - PubMed
-
- Borghi L, Meschi T, Guerra A, Novarini A. Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences. J Cardiovascular Pharmacology. 1993;22(Suppl 6):S78–S86. - PubMed
-
- Ettinger B, Pak CY, Citron JT, Thomas C, Adams-Huet B, Vangessel A. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. Journal of Urology. 1997;158(6):2069–2073. 158(6) - PubMed
-
- Ettinger B, Citron JT, Livermore B, Dolman LI. Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. Journal of Urology. 1988;139:679–684. - PubMed
-
- Ettinger B, Tang A, Citron JT, Livermore B, Williams T. Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med. 1986;315:1386–1389. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources